CURE Pharmaceutical (OTCMKTS:CURR – Get Rating) and Clever Leaves (NASDAQ:CLVR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Institutional & Insider Ownership 0.1% of CURE Pharmaceutical shares […]
Clever Leaves Reports Fourth Quarter and Full Year 2021 Results - Fourth Quarter and Full Year Revenue Increased 25% and 27%, Respectively - . | March 24, 2022